Ann Surg Oncol (2018) 25:1860–1867 https://doi.org/10.1245/s10434-018-6487-5 OR IG INA L A R TIC L E – PA NC REATIC TU MO RS Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally Waseem Lutﬁ, BS, Mazen S. Zenati, MD, MPH, PhD, Amer H. Zureikat, MD, Herbert J. Zeh, MD, and Melissa E. Hogg, MD, MS Scaife Hall, Pittsburgh ABSTRACT negative predictors of ET despite higher ET adherence Background and Purpose. National adherence to treat- overall (P \ 0.01). ment guidelines for pancreatic ductal adenocarcinoma Conclusions. Patient and hospital factors impact ET of (PDAC) is a concern. This study aims to evaluate national PDAC on a national level. These treatment disparities for expected treatment (ET) adherence for all PDAC stages. PDAC are concerning, even at high-volume academic We hypothesized that both patient and hospital demo- centers. Future studies need to identify the causes of graphics are associated with national ET disparities for treatment disparities for PDAC with intervention measures PDAC. aimed to relieve treatment disparities. Methods. Clinical stage I through IV PDAC patients were evaluated using the National Cancer Data Base from 2004 to 2013. ET was deﬁned as surgery for stage I/II, National adherence to treatment guidelines for chemotherapy
Annals of Surgical Oncology – Springer Journals
Published: Apr 24, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera